RE: Sp15 Mar 2024 20:55
My drivel probably holds little value, but, steph, there is often a point when fortunes are reversed. GROW is not like a penny mining stock nor a Phase 1 pharmaceutical developer. Grow, as we know invests in businesses that are in very early stage. Yes, they have an idea, a plan, probably sales and an enthusiastic workforce. They have al the potential for rapid growth or a cash haemorrhage only to limp onwards.
We as investors HAVE to trust the managers that decide whether to invest in the myriad of opportunities that are presented. After all, we probably all know a Kevin or a Paul that has aptitude for something and just lacks the cash to take on a new Molly to run the books, Tim to help on the floor or Amy to bill the customers and take payments - we none of us begrudge lending anything from £50 to £500 to help them buy the piece of equipment or the missing link to expand.
We are not dealing with these micro enterprises - this is the stage where not only have they exhausted parents, relatives, friends etc, but now they need the start of the big bucks. The costs to bridge the gap between a tiny business of 3-5 persons to a business that supports 20-50 people. It is the organic growth where insufficient cashflow and capitalisation will kill the entrepreneur that does not have deep pockets.
I know what the entrepreneur goes through - in the past I failed 5 times for 2 different reasons (1 was through embezzlement and 4 through lack of cash) but on the 6th, success resulted and business is in its 15th year of trading. I've not quite reached the salary of a Country let alone a City mouse, but a pretty good one for a Peasant one. Had I known about GROW or that ilk 50 or so years ago, I would certainly have made approach.
Sentiment changes. The valuation for GROW assumes most of the holdings are worthless. This cannot be correct and patience is needed.